Featured Resources
-
ACTA 2024-2025 Annual Report
Highlights of ACTAs activity and achievements during the 2024 – 2025 Financial Year.
-
Webinar recording: ICH GCP E6 (R3) guidelines: What’s New, What’s Changed, What’s Next!
On 2 April 2025, the GCP team from the Therapeutic Goods Administration (TGA) and Dr. Tanya Symons, an internationally recognised GCP expert, presented this insightful…
-
Consumer Involvement and Engagement Toolkit
The Consumer Involvement and Engagement Toolkit provides practical advice for researchers and research organisations wishing to conduct patient-centred clinical trials.
Search Resources
General search and filters
Filter by:
Topics
Type of Resource
Results filtered by:
-
Distributional cost-effectiveness analysis (DCEA) methods
-
ACTA 2024-2025 Annual Report
-
ACTA webinar – Estimating inequalities in health using quality-adjusted life expectancy: equity implications for health technology assessment and clinical trials
-
Teletrial insights: STOPNET (AGITG)
-
Teletrial insights: Socrates Trial (TROG)
-
Teletrial insights: MedCan 3 Trial (Mater Research)
-
Teletrials web resource
-
Teletrial insights: IMPEDE-PKD (AKTN)
-
Teletrial insights: Australasian Gastro-Intestinal Trials Group (AGITG)
-
The Australasian Type 1 Diabetes Immunotherapy Collaborative
-
ACTA Masterclass 5: Consumer Engagement
-
ACTA Consumer Reimbursement and Remuneration Policy